Measles is a major cause of mortality and morbidity in children receiving treatment for leukaemia. A review was made of all the documented cases of measles in children in first remission from acute lymphoblastic leukaemia at four major treatment centres in 1974-84. Over the 11 years reviewed 1043 children with acute lymphoblastic leukaemia were referred to these centres. Fifty one (4.9%) died while in first remission and 15 (29.4%) of these deaths were due to measles or its complications: 12 cases of pneumonia, 10 ofthem fatal; and six cases of encephalitis, five of them fatal and the sixth child left severely handicapped. These children would have had at least a 50% chance of long term survival.
Introduction
There are now effective treatment regimens for most childhood malignancies with disease free survival over five years being about 50%. The commonest childhood malignancy is acute lymphoblastic leukaemia, which now has at least a 60% five year disease free survival.' Unfortunately the treatment causes major immunosuppression, leaving the patient susceptible to infection during treatment and for several months thereafter, especially from viruses, Pneumocystis carinii, and to a lesser extent bacteria. The use of prophylactic co-trimoxazole has prevented P carinii pneumonitis very effectively.2 Varicella zoster immunoglobulin is effective in preventing varicella zoster, and acyclovir is useful in treating varicella zoster and herpes simplex. 3 The remaining major cause of mortality and morbidity from infection during immunosuppression is the measles virus.
If immunocompromised children contract measles they almost invariably have severe complications but often have few or none of the usual clinical features. In particular the rash may be mild and atypical or absent. The complications in the immunosuppressed take two main forms: the first and more common is a severe pneumonitis occurring at the time of the measles infection but OSBORN B EDEN, distinct from the secondary bacterial pneumonias seen in the nonimmunosuppressed. The second complication is a unique type of delayed encephalitis, also distinct from acute measles encephalomyelitis and subacute sclerosing panencephalitis seen in the nonimmunosuppressed. Both of these leukaemia related complications are usually fatal, although there are occasional long term survivors who suffer severe neurological handicap. The immunosuppression caused by both the leukaemia itself and its treatment may result in the suppression of any immunity previously acquired to measles from either past infection or immunisation. In the past the administration of routine active immunization has resulted in immunosuppressed children developing severe measles infection. Some Japanese workers have given a live attenuated measles vaccine to children with leukaemia and shown that it apparently produces a good antibody response with minimal side effects,5 but the experience in Britain ofgiving normal human immunoglobulin has shown that it does not always confer enough passive immunity to prevent measles infection.6 Further work is therefore required to find effective prophylaxis or treatment for this serious infection.
Patients and methods
The case notes of patients in first remission from acute lymphoblastic leukaemia known to have had measles infections during 1974-84 at four major paediatric treatment centres were extracted and the cases tabulated. The four centres were: the Royal Hospital for Sick Children, Glasgow; Royal Hospital for Sick Children, Edinburgh; Royal Manchester Children's Hospital; and Hospital for Sick Children, Great Ormond Street, London. In addition, the case notes of all the children treated in the haematology departments of the Royal Hospitals for Sick Children in Glasgow and Edinburgh in 1978-84 were reviewed. The policy adopted had been to give intramuscular injections of normal human immunoglobulin within 48 hours of any contact with measles during the "at risk" period-that is, during treatment and for six months afterwards. Table I shows the number of injections given to patients attending these two centres and the total number at risk. This was an attempt to assess the extent of the problem population throughout the period of the study. Five of the cases ofmeasles complications (two of pneumonia and three of encephalitis) occurred at the Royal Hospitals for Sick Children in Glasgow and Edinburgh; only the child with fatal pneumonia was given immunoglobulin. The measles infection itself was usually atypical or subclinical and only one patient had a typical rash preceded by Koplik's spots. Ten children had rashes that were not typical ofmeasles but were probablyassociated with the measles infection. The descriptions of the rashes were varied and included "transient erythematous," "macular," and "maculopapular," but all were mild and the distribution also varied. Only one child with an atypical rash also had Koplik's spots, and six patients had some or all of the symptoms associated with the prodromal period in non-immunocompromised patients-that is, fever, upper respiratory tract infection, and anorexia-and two patients had no clinical symptoms at all. Table II shows the details of the six cases of encephalitis. There was a definite history of contact in only three, and only one patient was given immunoglobulin. In these three patients the delay between the known BRITISH MEDICAL JOURNAL VOLUME 295 4 JULY 1987 contact and the onset of symptoms was "a few weeks," four months, and seven months. In the other three patients there was a history of atypical rash, which was taken retrospectively to have been possible measles infection, and the time lapse until the onset of symptoms of encephalitis was suppressed was that of a true measles pneumonitis rather than a secondary bacterial pneumonia as seen in the non-immunosuppressed, and antibiotics seemed to have little effect. In all of these patients both lungs were equally affected with progressive difficulty in ventilation due to "stiff lung" causing progressive hypoxia despite the use of increasing concentrations of oxygen, and cardiac arrest usually occurred as the terminal event within two to three weeks. Chest x ray films showed extensive bilateral consolidation with air bronchograms and three patients had pneumomediastinum, but appearances on x ray film were not specific for measles pneumonitis. It is a great tragedy that the 15 children who died had endured many months of investigation and treatment and were potentially cured of a malignant disease only to succumb to a "simple" and almost entirely preventable infection; the child who survived the encephalitis but was severely handicapped is unlikely to have a relapse of her leukaemia.
ENCEPHALITIS
In our experience the effect of the measles virus on the immuno- The phenomenon of the abnormal clinical picture of measles infection that presumably occurs because of the altered immunity of the patient can make initial diagnosis difficult, and a high index of suspicion of the possibility of measles must be maintained in those treating immunocompromised patients especially in cases of encephalitis, where there may be a delay of up to seven months from exposure to the virus. These complications were first described some years ago, but no effective treatment regimen has yet been found.7"
The answer to the problem seems to lie in prevention by drastically improving the uptake of measles vaccination in the community and by finding more effective prophylaxis for those immunocompromised patients known to have been exposed to the measles virus. If the vaccine uptake in the general population were to be increased to over 90% as it is in the United States of America,'2 13 as opposed to 50-60% as in some parts of the United Kingdom,'4 the herd immunity would be much improved and the risk of contact for those still susceptible would be greatly reduced. Children who are immunocompromised during the period of treatment (which can last up to three years) and for several months thereafter are encouraged to lead as normal a life as possible including attendance at school, though parents and teachers are warned about avoiding contact with infectious diseases. Several recent reports"'7 have shown that a major effort by the primary health care and community medicine teams can increase immunisation uptake enormously with subsequent benefit for the community (measles can still cause mortality and morbidity in otherwise healthy children)'8 9 as well as for special groups like immunocompromised patients. Even if the problem of the partial failure of the immunisation programme could be overcome, however, effective prophylaxis would still be needed and a trial of a new high dose intravenous hyperimmune globulin which has been produced by the Scottish National Blood Transfusion Service is being undertaken at the four centres which participated in this study and at the Royal Victoria Infirmary, Newcastle. (16239) . Those who had a history of measles were excluded from the trial. Both vaccinated and unvaccinated children (including those ineligible because of illness and those who defaulted from vaccination) were followed up by a nurse at three, six, and nine months to assess clinical reactions to the vaccine and establish the incidence of measles in each group.
Four previous reports have been published. The first described the design of the trial and covered the initial six months of the follow up. ' The second and third reports gave the results at two years nine months2 and four years nine months,3 respectively, and the fourth reported 12 years after vaccination. 4 The present report gives the results for a further nine years up to September 1985, 21 years after vaccination.
Subjects and methods
As previously stated,23 the number of participants in the trial was reduced after the first nine months. Over 2000 children from each of the three vaccine groups were lost to follow up when five of the participating local authority areas withdrew from the trial to take part in a community investigation.5 In addition, because of an undertaking given at the outset of the trial, vaccination was offered to the control group after the first nine months; 7000 children were vaccinated and were therefore lost to follow up as controls.
